000 01236 a2200373 4500
005 20250515113649.0
264 0 _c20080403
008 200804s 0 0 eng d
022 _a1534-6269
024 7 _a10.1007/s11912-008-0008-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGulati, Anthony P
245 0 0 _aThe clinical management of BRCA1 and BRCA2 mutation carriers.
_h[electronic resource]
260 _bCurrent oncology reports
_cJan 2008
300 _a47-53 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticarcinogenic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdiagnosis
650 0 4 _aChemoprevention
650 0 4 _aFemale
650 0 4 _aGenes, BRCA1
650 0 4 _aGenes, BRCA2
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGerm-Line Mutation
650 0 4 _aHumans
650 0 4 _aMass Screening
650 0 4 _aMastectomy
650 0 4 _aOvarian Neoplasms
_xdiagnosis
650 0 4 _aOvariectomy
650 0 4 _aRisk Reduction Behavior
700 1 _aDomchek, Susan M
773 0 _tCurrent oncology reports
_gvol. 10
_gno. 1
_gp. 47-53
856 4 0 _uhttps://doi.org/10.1007/s11912-008-0008-9
_zAvailable from publisher's website
999 _c17867266
_d17867266